Tenaya Therapeutics, Inc.
TNYA
$0.88
$0.033.61%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 5.98M | 5.57M | 6.71M | 6.46M | 5.96M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 20.78M | 20.94M | 24.08M | 27.54M | 24.65M |
| Operating Income | -20.78M | -20.94M | -24.08M | -27.54M | -24.65M |
| Income Before Tax | -20.18M | -20.28M | -23.28M | -26.86M | -23.84M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -20.18M | -20.28M | -23.28M | -26.86M | -23.84M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -20.18M | -20.28M | -23.28M | -26.86M | -23.84M |
| EBIT | -20.78M | -20.94M | -24.08M | -27.54M | -24.65M |
| EBITDA | -18.95M | -19.07M | -22.00M | -24.88M | -22.56M |
| EPS Basic | -0.12 | -0.12 | -0.14 | -0.24 | -0.28 |
| Normalized Basic EPS | -0.07 | -0.08 | -0.09 | -0.15 | -0.17 |
| EPS Diluted | -0.12 | -0.12 | -0.14 | -0.24 | -0.28 |
| Normalized Diluted EPS | -0.07 | -0.08 | -0.09 | -0.15 | -0.17 |
| Average Basic Shares Outstanding | 175.05M | 163.35M | 162.79M | 109.87M | 86.41M |
| Average Diluted Shares Outstanding | 175.05M | 163.35M | 162.79M | 109.87M | 86.41M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |